{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:07:44Z","timestamp":1787501264467,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10585-018-9925-7","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T01:23:18Z","timestamp":1532913798000},"page":"635-640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer"],"prefix":"10.1007","volume":"35","author":[{"given":"Philipp","family":"Horvath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Beckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Struller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"K\u00f6nigsrainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Andr\u00e9","family":"Reymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"issue":"5","key":"9925_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000227488","volume":"52","author":"J Klempnauer","year":"1995","unstructured":"Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R (1995) Surgery for exocrine pancreatic cancer\u2014who are the 5- and 10-year survivors? Oncology 52(5):353\u2013359","journal-title":"Oncology"},{"issue":"14","key":"9925_CR2","first-page":"255","volume":"105","author":"HG Beger","year":"2008","unstructured":"Beger HG, Rau B, Gansauge F, Leder G, Schwarz M, Poch B (2008) Pancreatic cancer\u2014low survival rates. Dtsch Arztebl Int 105(14):255\u2013262","journal-title":"Dtsch Arztebl Int"},{"issue":"7","key":"9925_CR3","first-page":"563","volume":"63","author":"P Heeckt","year":"1992","unstructured":"Heeckt P, Safi F, Binder T, B\u00fcchler M (1992) Free intraperitoneal tumors cells in pancreatic cancer\u2014significance for clinical course and therapy. Chirurg 63(7):563\u2013567","journal-title":"Chirurg"},{"key":"9925_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00280-013-2368-6","volume":"73","author":"K Sudo","year":"2014","unstructured":"Sudo K, Ishihara T, Hirata N et al (2014) Randomized controlled study of gemcitabine plsu S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer. Cancer Chemother Pharmacol 73:389\u2013396","journal-title":"Cancer Chemother Pharmacol"},{"key":"9925_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1634\/theoncologist.2014-0394","volume":"20","author":"J Tabarnero","year":"2015","unstructured":"Tabarnero J, Chiorean EG, Infante JR et al (2015) Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer. Oncologist 20:143\u2013150","journal-title":"Oncologist"},{"key":"9925_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12885-016-3004-8","volume":"17","author":"CB Tempfer","year":"2017","unstructured":"Tempfer CB, Hartmann F, Hilal Z, Rezniczek GA (2017) Intraperitoneal cisplatin and doxorubicin as maintenance chemotherapy for unresectable ovarian cancer: a case report. BMC Cancer 17:26","journal-title":"BMC Cancer"},{"key":"9925_CR7","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.ejso.2015.06.001","volume":"41","author":"K Odendahl","year":"2015","unstructured":"Odendahl K, Solass W, Demtr\u00f6der C, Giger-Pabst U et al (2015) Quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Eur J Surg Oncol 41:1379\u20131385","journal-title":"Eur J Surg Oncol"},{"key":"9925_CR8","first-page":"4596176","volume":"2017","author":"H Teixeira Frainha","year":"2017","unstructured":"Teixeira Frainha H, Grass F, Kefleyesus A, Achtari C et al (2017) Impact of pressurized intraperitoneal aerosol chemotherapy on quality of life and symptoms in patients with peritoneal carcinomatosis: a retrospective cohort analysis. Gastroenterol Res Pract 2017:4596176","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"9925_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10585-017-9849-7","volume":"34","author":"M Graversen","year":"2017","unstructured":"Graversen M, Detlefsen S, Bjerregaard JK, Pfeiffer P et al (2017) Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Clin Exp Metastasis 34(5):309\u2013314","journal-title":"Clin Exp Metastasis"},{"key":"9925_CR10","first-page":"373","volume":"38","author":"TA Falkenstein","year":"2018","unstructured":"Falkenstein TA, G\u00f6tze TO, Ouaissi M, Tempfer CB, Giger-Pabst U, Demtr\u00f6der C (2018) First clinical data of pressurized intraperitoneal aerosol chemotherapy (PIPAC) as salvage therapy for peritoneal metastatic biliary tract cancer. Anticancer Res 38:373\u2013378","journal-title":"Anticancer Res"},{"issue":"5","key":"9925_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10585-017-9851-0","volume":"34","author":"JP Sleeman","year":"2017","unstructured":"Sleeman JP (2017) PIPAC puts pressure on peritoneal metastases from pancreatic cancer. Clin Exp Metastasis 34(5):291\u2013293","journal-title":"Clin Exp Metastasis"},{"key":"9925_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/6852749","volume":"2017","author":"Martin H\u00fcbner","year":"2017","unstructured":"Kurtz F, Struller F, Horvath P, Solass W, B\u00f6sm\u00fcller H, K\u00f6nigsrainer A, Reymond MA. Feasibility, safety and efficacy of Pressurizes IntraPeritoneal Aerosol Chemotherapy (PIPAC) for peritoneal metastases: a registry study. Gastroenterol Res Pract. https:\/\/doi.org\/10.1155\/2017\/6852749","journal-title":"Gastroenterology Research and Practice"},{"key":"9925_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","volume":"21","author":"W Solass","year":"2014","unstructured":"Solass W, Kerb R, Mu\u00c8rdter T, Giger-Pabst U et al (2014) Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol 21:553\u2013559","journal-title":"Ann Surg Oncol"},{"key":"9925_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/codi.13130","volume":"18","author":"C Demtr\u00f6der","year":"2016","unstructured":"Demtr\u00f6der C, Solass W, Zieren J, Strumberg D et al (2016) Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis 18:364\u2013371","journal-title":"Colorectal Dis"},{"key":"9925_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","volume":"20","author":"G Nadiradze","year":"2016","unstructured":"Nadiradze G, Giger-Pabst U, Zieren J, Strumberg D et al (2016) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis. J Gastrointest Surg 20:367\u2013373","journal-title":"J Gastrointest Surg"},{"issue":"Suppl. 1","key":"9925_CR16","first-page":"S2","volume":"20","author":"PH Sugarbaker","year":"2015","unstructured":"Sugarbaker PH (2015) Management of peritoneal metastases\u2014basic concepts. J BUON 20(Suppl. 1):S2\u2013S11","journal-title":"J BUON"},{"key":"9925_CR17","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","volume":"31","author":"D Go\u00c8hler","year":"2017","unstructured":"Go\u00c8hler D, Khosrawipour V, Khosrawipour T, Diaz-Carballo D et al (2017) Technical description of the microinjection pump (MIP) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Endosc 31:1778\u20131784","journal-title":"Surg Endosc"},{"key":"9925_CR18","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.21873\/anticanres.11008","volume":"36","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Khosrawipour T, Falkenstein TA, Diaz-Carballo D et al (2016) Evaluating the effect of micropump position, internal pressure and doxorubicin dosage on efficacy of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model. Anticancer Res 36:4595\u20134600","journal-title":"Anticancer Res"},{"key":"9925_CR19","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1245\/s10434-013-3039-x","volume":"20","author":"W Solass","year":"2013","unstructured":"Solass W, Giger-Pabst U, Zieren J, Reymond MA (2013) Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. Ann Surg Oncol 20:3504\u20133511","journal-title":"Ann Surg Oncol"},{"key":"9925_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/pp-2016-0011","volume":"1","author":"W Solass","year":"2016","unstructured":"Solass W, Sempoux C, Detlefsen S, Carr NJ et al (2016) Peritoneal sampling and histological assessment of therapeutiv response in peritoneal metastasis: proposal of the peritoneal regression grading score (PRGS). Pleura Peritoneum 1:99\u2013108","journal-title":"Pleura Peritoneum"},{"key":"9925_CR21","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0. Published: May 28, 2009 (v4.03: June 14, 2010). U.S. Department of Health and Human Services. National Institutes of Health, National Cancer Institute"},{"key":"9925_CR22","first-page":"161862","volume":"2011","author":"PH Sugarbaker","year":"2011","unstructured":"Sugarbaker PH, Stuart A, Bijelic L (2011) Intrapertioneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data. Int J Surg Oncol 2011:161862","journal-title":"Int J Surg Oncol"},{"key":"9925_CR23","doi-asserted-by":"publisher","first-page":"506571","DOI":"10.1155\/2012\/506571","volume":"2012","author":"AA Tentes","year":"2012","unstructured":"Tentes AA, Kyziridis D, Kakolyris S, Pallas N et al (2012) Preliminary results of hyperthermic intraperitoneal chemotherapy as an adjuvant in resectable pancreatic cancer. Gastroenterol Res Pract 2012:506571","journal-title":"Gastroenterol Res Pract"},{"key":"9925_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1200\/JCO.2012.44.4869","volume":"31","author":"S Gourgou-Bourgade","year":"2013","unstructured":"Gourgou-Bourgade S, Bascoul-Mollevi C, Desseigne F, Ychou M et al (2013) Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4\/ACCORD 11 randomized trial. J Clin Oncol 31:23\u201329","journal-title":"J Clin Oncol"},{"key":"9925_CR25","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"12","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, Maughan TS et al (2016) Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomized trials from the Analysis and Research in Cancer of Digestive System (ARCAD) database. Lancet Oncol 12:1709\u20131719","journal-title":"Lancet Oncol"},{"key":"9925_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrclinonc.2009.217","volume":"7","author":"WP Ceelen","year":"2010","unstructured":"Ceelen WP, Flessner MF (2010) Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol 7:108\u2013115","journal-title":"Nat Rev Clin Oncol"},{"key":"9925_CR27","first-page":"1035","volume":"296","author":"SH Jang","year":"2001","unstructured":"Jang SH, Wientjes MG, Au JLS (2001) Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule. JPharmacolExp Ther 296:1035\u20131042","journal-title":"JPharmacolExp Ther"},{"key":"9925_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/01.sla.0000218089.61635.5f","volume":"244","author":"P Esquis","year":"2006","unstructured":"Esquis P, Consolo D, Magnin G, Pointaire P et al (2006) High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg 244:106\u2013112","journal-title":"Ann Surg"},{"key":"9925_CR29","doi-asserted-by":"publisher","first-page":"e0186709","DOI":"10.1371\/journal.pone.0186709","volume":"12","author":"T Khosrawipour","year":"2017","unstructured":"Khosrawipour T, Khosrawipour V, Giger-Pabst U (2017) Pressurized intra peritoneal aerosol chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma. PLoS ONE 12:e0186709","journal-title":"PLoS ONE"},{"key":"9925_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","volume":"137","author":"CB Tempfer","year":"2015","unstructured":"Tempfer CB, Winnekendonk G, Solass W, Horvat R et al (2015) Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer. A phase 2 study. Gynecol Oncol 137:223\u2013228","journal-title":"Gynecol Oncol"},{"key":"9925_CR31","doi-asserted-by":"crossref","unstructured":"Struller F, Horvath P, Solass W et al (2017) Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis (PIPAC-GA1). ASCO GI meeting 2017; abstract 99","DOI":"10.1200\/JCO.2017.35.4_suppl.99"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-018-9925-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-018-9925-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-018-9925-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T18:22:40Z","timestamp":1604686960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-018-9925-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["9925"],"URL":"https:\/\/doi.org\/10.1007\/s10585-018-9925-7","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]},"assertion":[{"value":"19 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Marc Andre Reymond holds several patents for PIPAC and related technologies and shareholder of Capnomed GmbH, Villigendorf, Germay.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}